Group name
MIRP
BCR
197 (14.1)
Continence
1,036/1,358 (76.3)
remark
Continence rate
Survival outcome
1 (0.1)
remark
Death from prostate cancer, No. (%)
Survival outcome
1 (0.1)
remark
Death from prostate cancer, No. (%)
Other Outcomes
36 (2.4)
remark
Distant metastasis, No. (%)
Follow Up Time
at 1 yr